SIA "IS GROUP PHARMA"
Copy
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2025-01-09
Change of equity capital2025-01-09
Change in members2025-01-09
Unidentified type of change2024-12-04
Unidentified type of changeSuspensions
No suspension
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
10Debts
0.00 €
0 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
1
Credit limit
***** €
Turnover
2-5 M €
+56.06 %Business linkages
4Linkages with other companies
Financial ratios
Net Profit (€)
498,142
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
498,142EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2023 |
|---|
| 2,918,077 |
| 224,467 |
| 189,122 |
| 189,031 |
| 14,541 |
| 22.03 |
| 6.48 |
| 1,200,992 |
| 124,591 |
| 95,968 |
| 1,229,615 |
| 2024 |
|---|
| 2,482,474 |
| 190,960 |
| 84,133 |
| 84,007 |
| 6,462 |
| 21.35 |
| 3.38 |
| 1,284,999 |
| 164,080 |
| 160,687 |
| 1,288,392 |
| 2025 |
|---|
| 3,874,233 |
| 387,423 |
| 498,145 |
| 498,142 |
| 49,814 |
| 22.21 |
| 12.86 |
| 1,615,332 |
| 112,488 |
| 131,974 |
| 1,595,846 |
Register and
explore Okredo data| 2025 |
|---|
| 3,874,233 |
| 387,423 |
| 498,145 |
| 498,142 |
| 49,814 |
| 22.21 |
| 12.86 |
| 1,615,332 |
| 112,488 |
| 131,974 |
| 1,595,846 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
3,874,233 €
56 % *
Sales per employee (€)
387,423 €103 % *
Profit before tax (€)
498,145 €492 % *
Net Profit (€)
498,142 €493 % *
Profit per employee (€)
49,814 €671 % *
Total profitability (%)
22.21 %4.03 % *
Net profitability (%)
12.86 %280.47 % *
Equity (€)
1,615,332 €26 % *
Amounts Payable And Liabilities (€)
112,488 €
-31 % *
Non-current Assets (€)
131,974 €-18 % *
Current Assets (€)
1,595,846 €
24 % *
Credit history
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Premium users: 1.00 credit
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(4)
Plaintiff
(1)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
07/04/2026C771067124SKC-0330-26 | Claimant:Individual person Respondent:SIA "IS GROUP PHARMA" | Reason: par uzteikuma atzīšanu par spēkā neesošu un darba attiecību atjaunošanu Decision: Open | Augstākās tiesas Senāts | 1 |  |
11/06/2025C771067124CA-0994-25 | Claimant:Individual person Respondent:SIA "IS GROUP PHARMA" | Reason: par uzteikuma atzīšanu par spēkā neesošu un darba attiecību atjaunošanu Decision: Open | Rīgas apgabaltiesa | 2 | |
17/02/2025C771067124CA-0809-25 | Claimant:Individual person Respondent:SIA "IS GROUP PHARMA" | Reason: par uzteikuma atzīšanu par spēkā neesošu un darba attiecību atjaunošanu Decision: Open | Rīgas apgabaltiesa | 1 | |
01/11/2024C771067124C-10671-24 | Claimant:Individual person Respondent:SIA "IS GROUP PHARMA" | Reason: par uzteikuma atzīšanu par spēkā neesošu un darba attiecību atjaunošanu Decision: Open | Rīgas pilsētas tiesa | 9 | |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
20/08/2026C71424725C-1413-26 | Claimant:SIA "IS GROUP PHARMA" Respondent:Bellatexim SIA | Reason: Prasības pieteikums vienkāršotajā procedūrā par naudas piedziņu (83) Decision: Open | Vidzemes rajona tiesa | 3 | |
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 149,040 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 182,260 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 69,040 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 56,430 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| Total amount: 190,770 |
Similar companies
Category:
Wholesale of other food, including fish, crustaceans and molluscsComp. code:
40203154263Reg. date:
06/07/2018Turnover:
-No. of employees:
11Category:
Wholesale of other food, including fish, crustaceans and molluscsComp. code:
40203063871Reg. date:
19/04/2017Turnover:
-No. of employees:
11Category:
Wholesale of other food, including fish, crustaceans and molluscsComp. code:
40103856211Reg. date:
18/12/2014Turnover:
-No. of employees:
8Category:
Wholesale of other food, including fish, crustaceans and molluscsComp. code:
40103839283Reg. date:
23/10/2014Turnover:
-No. of employees:
7Category:
Wholesale of other food, including fish, crustaceans and molluscsComp. code:
41203052580Reg. date:
05/09/2014Turnover:
-No. of employees:
13